These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 22678813)
21. Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutations. Slynko I; Nguyen S; Hamilton EMC; Wisse LE; de Esch IJP; de Graaf C; Bruning JB; Proud CG; Abbink TEM; van der Knaap MS Mol Genet Genomic Med; 2021 Mar; 9(3):e1593. PubMed ID: 33432707 [TBL] [Abstract][Full Text] [Related]
22. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5. Matsukawa T; Wang X; Liu R; Wortham NC; Onuki Y; Kubota A; Hida A; Kowa H; Fukuda Y; Ishiura H; Mitsui J; Takahashi Y; Aoki S; Takizawa S; Shimizu J; Goto J; Proud CG; Tsuji S Neurogenetics; 2011 Aug; 12(3):259-61. PubMed ID: 21484434 [No Abstract] [Full Text] [Related]
23. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter]. Pan YX; Wu Y; Niu ZP; Jiang YW Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687 [TBL] [Abstract][Full Text] [Related]
24. Vanishing white matter disease with different faces. Güngör G; Güngör O; Çakmaklı S; Maraş Genç H; İnce H; Yeşil G; Dilber C; Aydın K Childs Nerv Syst; 2020 Feb; 36(2):353-361. PubMed ID: 31385086 [TBL] [Abstract][Full Text] [Related]
25. Efficient detection of frequent eIF2B mutations for the rapid molecular diagnosis of CACH/VWM syndrome. Ferreira MC; Dorboz I; Boespflug-Tanguy O Clin Biochem; 2015 Dec; 48(18):1317-23. PubMed ID: 26162493 [TBL] [Abstract][Full Text] [Related]
27. Vanishing white matter. van der Knaap MS; Bugiani M; Abbink TEM Handb Clin Neurol; 2024; 204():77-94. PubMed ID: 39322396 [TBL] [Abstract][Full Text] [Related]
28. Adult-onset leukodystrophy with vanishing white matter: a case series of 19 patients. Benzoni C; Moscatelli M; Farina L; Magri S; Ciano C; Scaioli V; Alverà S; Cammarata G; Bianchi-Marzoli S; Castellani M; Zito FM; Marotta G; Piacentini S; Villacara A; Mantegazza R; Gellera C; Durães J; Gouveia A; Matos A; do Carmo Macário M; Pareyson D; Taroni F; Di Bella D; Salsano E J Neurol; 2023 Sep; 270(9):4219-4234. PubMed ID: 37171481 [TBL] [Abstract][Full Text] [Related]
29. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature. Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145 [TBL] [Abstract][Full Text] [Related]
30. Adult Vanishing White Matter Disease with a Novel EIF2B4 Mutation. Su T; Yuan H; Gao W; Li H; Yuan M J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS181-SS183. PubMed ID: 36597332 [TBL] [Abstract][Full Text] [Related]
31. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386 [TBL] [Abstract][Full Text] [Related]
32. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up. Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199 [TBL] [Abstract][Full Text] [Related]
33. Vanishing white matter disease: imaging, clinical and molecular correlation in Brazilian families. Albacete MAP; Simão GN; Lourenço CM; Dos Santos AC Neuroradiology; 2024 Sep; 66(9):1553-1564. PubMed ID: 38886214 [TBL] [Abstract][Full Text] [Related]
34. Leukodystrophy Due to Shivaram S; Nagappa M; Seshagiri DV; Saini J; Govindaraj P; Sinha S; Bindu PS; Taly AB Can J Neurol Sci; 2022 Sep; 49(5):708-712. PubMed ID: 34663487 [TBL] [Abstract][Full Text] [Related]
35. A rare mutation in EIF2B4 gene in an epileptic child with vanishing white matter disease: a case report. Gungor O; Ozkaya AK; Hirfanoglu T; Dilber C; Aydin K Genet Couns; 2015; 26(1):41-6. PubMed ID: 26043506 [TBL] [Abstract][Full Text] [Related]
36. Identification of a Missense Variant in the EIF2B3 Gene Causing Vanishing White Matter Disease with Antenatal-Onset but Mild Symptoms and Long-Term Survival. Khorrami M; Khorram E; Yaghini O; Rezaei M; Hejazifar A; Iravani O; Yazdani V; Riahinezhad M; Kheirollahi M J Mol Neurosci; 2021 Nov; 71(11):2405-2414. PubMed ID: 33687620 [TBL] [Abstract][Full Text] [Related]
37. Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis. Xu L; Zhong M; Yang Y; Wang M; An N; Xu X; Zhu Y; Li Z; Chen H; Zhao R; Zheng X Neurol Sci; 2022 Apr; 43(4):2659-2667. PubMed ID: 34755279 [TBL] [Abstract][Full Text] [Related]
38. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease]. Kashiwagi K; Ito T; Yokoyama S Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977 [TBL] [Abstract][Full Text] [Related]
39. Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients. Ren Y; Yu X; Chen B; Tang H; Niu S; Wang X; Pan H; Zhang Z Neurol Sci; 2022 Aug; 43(8):4961-4977. PubMed ID: 35389136 [TBL] [Abstract][Full Text] [Related]
40. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation. Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]